HTL-STREFA Inc. Introduces DropSafe® Sicura™ as a Safe Alternative Amid FDA Concerns

In the wake of concerns expressed by the U.S. Food and Drug Administration (FDA) regarding plastic syringes and safety needles manufactured in China, HTL-STREFA Inc., a subsidiary of the MTD Group, announces its European-produced DropSafe® Sicura™ passive safety needle. This product is the first of its kind in North America, designed to prevent needlestick injuries, thereby enhancing the safety of healthcare providers and patients alike.

Manufactured under rigorous quality control standards in Europe, the DropSafe® Sicura™ passive safety needle introduces a transparent shield that locks automatically post-injection, eliminating the need for manual activation by healthcare professionals. This innovative design launched in the U.S. and Canada in 2023, aims to eliminate needlestick injuries and provide a safe injection experience.

HTL-STREFA Inc.'s readiness to support the demand for safer medical supplies in North America was highlighted by Carl Ward, General Manager. He stated the company's substantial capacity and infrastructure in the U.S. and Canada to assist healthcare systems transition smoothly to reliable alternatives, ensuring uninterrupted patient care.

With a legacy spanning over three decades, HTL-STREFA Inc. and its parent company, MTD Group, continue to uphold their commitment to safety, excellence, and innovation in medical technology. They aim to support healthcare professionals and enhance patient outcomes through advanced solutions and impeccable service.